Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 430.379B	--
--	2025/Q4	-- / 447.861B	--
Feb 4, 2025	2025/Q3	517.408B / 433.900B	--
Oct 30, 2024	2025/Q2	462.497B / 425.282B	--
Aug 1, 2024	2025/Q1	473.124B / 411.415B	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 430.379B--

--2025/Q4-- / 447.861B--

Feb 4, 20252025/Q3517.408B / 433.900B--

Oct 30, 20242025/Q2462.497B / 425.282B--

Aug 1, 20242025/Q1473.124B / 411.415B--

Unlock Free Earnings Estimates

Open Account

Astellas Pharma: Extraordinary Report

Feb 4 01:40 ET

Astellas Pharma: Extraordinary Report

Feb 4 01:39 ET

Astellas Pharma: Financial results briefing materials for the 3rd quarter of the fiscal year ending March 31, 2025

Feb 4 01:30 ET

Astellas Pharma: Supplemental financial results for the 3rd quarter of the fiscal year ending March 31, 2025

Feb 4 01:30 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Mar 5, 2025

Buy

No Data